Nuwellis, Inc.

Nuwellis, Inc.verified

NUWE

Price:

$1.36

Market Cap:

$2.54M

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, ...[Read more]

Industry

Medical - Devices

IPO Date

2012-02-16

Stock Exchange

NASDAQ

Ticker

NUWE

The ROE as of November 2024 (TTM) for Nuwellis, Inc. (NUWE) is -1671.56%

According to Nuwellis, Inc.’s latest financial reports and current stock price. The company's current ROE is -1671.56%. This represents a change of 1.13% compared to the average of -135.58% of the last 4 quarters.

Nuwellis, Inc. (NUWE) Historical ROE (quarterly & annually)

How has NUWE ROE performed in the past?

The mean historical ROE of Nuwellis, Inc. over the last ten years is -345.03%. The current -1671.56% ROE has changed 384.46% with respect to the historical average. Over the past ten years (40 quarters), NUWE's ROE was at its highest in in the June 2024 quarter at 113.04%. The ROE was at its lowest in in the March 2024 quarter at -428.14%.

Quarterly (TTM)
Annual

Average

-345.03%

Median

-167.98%

Minimum

-910.25%

Maximum

-75.45%

Nuwellis, Inc. (NUWE) ROE by Quarter and Year

Discovering the peaks and valleys of Nuwellis, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 475.00%

Maximum Annual ROE = -75.45%

Minimum Annual Increase = -90.83%

Minimum Annual ROE = -910.25%

Quarterly (TTM)
Annual
YearROEChange
2023-675.89%475.00%
2022-117.54%55.78%
2021-75.45%-22.25%
2020-97.05%-89.34%
2019-910.25%217.24%
2018-286.93%248.16%
2017-82.41%-90.83%
2016-898.80%311.52%
2015-218.41%149.38%
2014-87.58%108.21%

Nuwellis, Inc. (NUWE) Average ROE

How has NUWE ROE performed in the past?

The current ROE of Nuwellis, Inc. (NUWE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-289.63%

5-year avg

-375.24%

10-year avg

-345.03%

Nuwellis, Inc. (NUWE) ROE vs. Peers

How is NUWE’s ROE compared to its peers?

Nuwellis, Inc.’s ROE is greater than ReShape Lifesciences Inc. (-208.37%), greater than Tenon Medical, Inc. (-715.68%), greater than Ra Medical Systems, Inc. (-347.48%), greater than INVO Bioscience, Inc. (-1073.76%), greater than ThermoGenesis Holdings, Inc. (-762.31%), greater than Sintx Technologies, Inc. (-89.99%), greater than NanoVibronix, Inc. (-74.98%), greater than Tivic Health Systems, Inc. (-172.08%), greater than Talis Biomedical Corporation (-79.73%), greater than Bluejay Diagnostics, Inc. (-187.00%), greater than Heart Test Laboratories, Inc. (-144.10%), greater than Helius Medical Technologies, Inc. (-258.06%), greater than Bone Biologics Corporation (-154.16%),

Build a custom stock screener for Nuwellis, Inc. (NUWE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuwellis, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuwellis, Inc. (NUWE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuwellis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Nuwellis, Inc.'s ROE?

How is the ROE calculated for Nuwellis, Inc. (NUWE)?

What is the highest ROE for Nuwellis, Inc. (NUWE)?

What is the 3-year average ROE for Nuwellis, Inc. (NUWE)?

What is the 5-year average ROE for Nuwellis, Inc. (NUWE)?

How does the current ROE for Nuwellis, Inc. (NUWE) compare to its historical average?